Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-26
DOI
10.3389/fgene.2021.670384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-associated myeloid cells: diversity and therapeutic targeting
- (2021) Alberto Mantovani et al. Cellular & Molecular Immunology
- Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis
- (2020) Kerrie L. Marie et al. Nature Communications
- Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway
- (2020) Victor Delprat et al. Scientific Reports
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer
- (2020) Yifan Liu et al. Journal of Translational Medicine
- Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
- (2020) Wanzun Lin et al. Frontiers in Oncology
- Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
- (2020) Zhuomao Mo et al. Frontiers in Genetics
- Tumor-Associated Macrophage Status in Cancer Treatment
- (2020) Anna Maria Malfitano et al. Cancers
- A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
- (2020) Baohui Zhang et al. Journal of Translational Medicine
- Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
- (2020) Irina Larionova et al. Frontiers in Oncology
- Targeting tumor-associated macrophages as an antitumor strategy
- (2020) Nan Cheng et al. BIOCHEMICAL PHARMACOLOGY
- Stanniocalcin‑1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl‑2
- (2019) Yan Wang et al. ONCOLOGY REPORTS
- Accumulation of fructose 1,6-bisphosphate protects clear cell renal cell carcinoma from oxidative stress
- (2019) Jun Wang et al. LABORATORY INVESTIGATION
- Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
- (2019) Charles C. Guo et al. Cell Reports
- A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients
- (2019) Yi-feng Zou et al. Cancer Cell International
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- STC1 regulates glioblastoma migration and invasion via the TGF‑β/SMAD4 signaling pathway
- (2019) Yan Xiong et al. Molecular Medicine Reports
- Significance of TP53 mutation in bladder cancer disease progression and drug selection
- (2019) Guang Wu et al. PeerJ
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- MAPK/AP‑1 pathway regulates benzidine‑induced cell proliferation through the control of cell cycle in human normal bladder epithelial cells
- (2018) Li Zhao et al. Oncology Letters
- O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia
- (2018) Tingsheng Lin et al. Theranostics
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
- (2018) Lingjian Yang et al. EBioMedicine
- Molecular Subtypes of Bladder Cancer
- (2018) David J. McConkey et al. Current Oncology Reports
- Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
- (2017) Woonyoung Choi et al. EUROPEAN UROLOGY
- Tp53 and its potential therapeutic role as a target in bladder cancer
- (2017) Chiara Ciccarese et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation
- (2017) Victor Ushakov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1
- (2017) Mei Xue et al. Molecular Cancer
- Targeted O -glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours
- (2017) Sofia Cotton et al. Molecular Oncology
- Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy
- (2017) Kenneth M. Felsenstein et al. Nature Reviews Urology
- Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing
- (2017) Jixi Liu et al. TUMOR BIOLOGY
- Tumor heterogeneity offibroblast growth factor receptor 3(FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
- (2016) D. Pouessel et al. ANNALS OF ONCOLOGY
- Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
- (2016) J J Irlam-Jones et al. BRITISH JOURNAL OF CANCER
- STC1 and NF-κB p65 (Rel A) is Constitutively Activated in Colorectal Cancer
- (2016) Saleheh Rezapour et al. Clinical Laboratory
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
- (2016) Jun He et al. OncoTargets and Therapy
- Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma
- (2015) Qi-fei Tao et al. Molecular Cancer
- The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- (2015) Thomas R. Cox et al. NATURE
- Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells
- (2015) Elizabeth C. Finger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- STC1 expression is associated with tumor growth and metastasis in breast cancer
- (2014) Andy C-M Chang et al. CLINICAL & EXPERIMENTAL METASTASIS
- FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
- (2014) Elizabeth A. Guancial et al. Cancer Medicine
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- Hypoxia-inducible factor-1 expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma
- (2007) C-Y Chai et al. JOURNAL OF CLINICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More